Login / Signup

An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).

Stephen Ian WalimbwaJulian P KaboggozaCatriona WaittPauline Byakika-KibwikaAntonio D'AvolioMohammed Lamorde
Published in: Trials (2021)
ClinicalTrials.gov NCT04385719 . Registered 13 May 2020.
Keyphrases
  • hiv infected patients
  • antiretroviral therapy
  • open label
  • double blind
  • high dose
  • randomized controlled trial
  • phase ii
  • low dose
  • study protocol